|
EP2211615A4
(en)
*
|
2007-10-22 |
2010-10-13 |
Glaxosmithkline Llc |
PYRIDOSULFONAMIDE DERIVATIVES AS PI3 KINASE INHIBITORS
|
|
US20100048913A1
(en)
|
2008-03-14 |
2010-02-25 |
Angela Brodie |
Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
|
|
CA2725014C
(en)
|
2008-05-30 |
2014-06-17 |
Amgen Inc. |
Inhibitors of pi3 kinase
|
|
BRPI0917540A2
(pt)
|
2008-08-05 |
2015-11-17 |
Daiichi Sankyo Co Ltd |
composto, sal farmacologicamente aceitavél, composição farmacêutica, e, uso de um composto ou sal farmacologicamente aceitável
|
|
EA024252B1
(ru)
|
2009-01-08 |
2016-08-31 |
Кьюрис, Инк. |
Ингибиторы фосфоинозитид-3-киназ с цинксвязывающей группой
|
|
CN102686600A
(zh)
|
2009-02-05 |
2012-09-19 |
托凯药业股份有限公司 |
甾体cyp17抑制剂/抗雄激素物质的新型药物前体
|
|
US8765747B2
(en)
*
|
2009-06-12 |
2014-07-01 |
Dana-Farber Cancer Institute, Inc. |
Fused 2-aminothiazole compounds
|
|
NZ598220A
(en)
|
2009-08-17 |
2014-02-28 |
Intellikine Llc |
Heterocyclic compounds and uses thereof
|
|
WO2011090738A2
(en)
|
2009-12-29 |
2011-07-28 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
|
US20110319405A1
(en)
*
|
2010-06-28 |
2011-12-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Treatment and prevention of diffuse parenchymal lung disease by selective active-site mTOR inhibitors
|
|
UY33337A
(es)
|
2010-10-18 |
2011-10-31 |
Respivert Ltd |
DERIVADOS SUSTITUIDOS DE 1H-PIRAZOL[ 3,4-d]PIRIMIDINA COMO INHIBIDORES DE LAS FOSFOINOSITIDA 3-QUINASAS
|
|
WO2012116237A2
(en)
|
2011-02-23 |
2012-08-30 |
Intellikine, Llc |
Heterocyclic compounds and uses thereof
|
|
WO2012135571A1
(en)
|
2011-04-01 |
2012-10-04 |
Curis, Inc. |
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
|
|
JP2014528412A
(ja)
*
|
2011-09-30 |
2014-10-27 |
キネタ・インコーポレイテツド |
抗ウイルス化合物
|
|
HK1202333A1
(en)
*
|
2011-11-11 |
2015-09-25 |
Intellikine, Llc |
Combination of kinase inhibitors and uses thereof
|
|
US9382239B2
(en)
|
2011-11-17 |
2016-07-05 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-Jun-N-terminal kinase (JNK)
|
|
WO2013142245A1
(en)
*
|
2012-03-23 |
2013-09-26 |
Memorial Sloan-Kettering Cancer Center |
Potentiating antibody-induced complement-mediated cytotoxicity via pi3k inhibition
|
|
PT2897644T
(pt)
*
|
2012-09-20 |
2018-10-16 |
Novartis Ag |
Associação farmacêutica compreendendo um inibidor de fosfatidilinositol 3-quinase e um inibidor da aromatase
|
|
EP2909194A1
(en)
|
2012-10-18 |
2015-08-26 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
|
USRE48175E1
(en)
|
2012-10-19 |
2020-08-25 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
|
WO2014063054A1
(en)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
|
|
US9073946B2
(en)
|
2013-01-15 |
2015-07-07 |
Kineta, Inc. |
Anti-viral compounds
|
|
WO2014158649A1
(en)
*
|
2013-03-13 |
2014-10-02 |
Dow Agrosciences Llc |
Preparation of 1,3-(substituted-diaryl)-1,2,4-triazoles
|
|
US20140275564A1
(en)
*
|
2013-03-13 |
2014-09-18 |
Dow Agrosciences Llc |
Process for the preparation of certain triaryl rhamnose carbamates
|
|
RU2015137617A
(ru)
|
2013-03-14 |
2017-04-18 |
Юниверсити Оф Мэриленд, Балтимор Офис Оф Текнолоджи Трансфер |
Агенты, подавляющие андрогенные рецепторы, и их применение
|
|
CN105636594A
(zh)
|
2013-08-12 |
2016-06-01 |
托凯药业股份有限公司 |
使用雄激素靶向疗法用于治疗肿瘤性疾病的生物标记物
|
|
EP3053926B1
(en)
|
2013-09-30 |
2018-08-08 |
Shanghai Yingli Pharmaceutical Co. Ltd. |
Fused pyrimidine compound, intermediate, preparation method therefor, and composition and application thereof
|
|
EP3057956B1
(en)
|
2013-10-18 |
2021-05-05 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7)
|
|
WO2015058126A1
(en)
|
2013-10-18 |
2015-04-23 |
Syros Pharmaceuticals, Inc. |
Heteroaromatic compounds useful for the treatment of prolferative diseases
|
|
LT3466955T
(lt)
|
2014-01-13 |
2021-02-25 |
Aurigene Discovery Technologies Limited |
Oksazol[4,5-b]piridino ir tiazol[4,5-b]piridino darinių, kaip irak4 inhibitorių, skirtų vėžio gydymui, gamybos būdas
|
|
WO2015108861A1
(en)
|
2014-01-14 |
2015-07-23 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
WO2015108881A1
(en)
|
2014-01-14 |
2015-07-23 |
Millennium Pharmaceuticals, Inc. |
Heteroaryls and uses thereof
|
|
CA2943609A1
(en)
|
2014-03-27 |
2015-10-01 |
The Brigham And Women's Hospital, Inc. |
Metabolically-activated drug conjugates to overcome resistance in cancer therapy
|
|
WO2015164614A1
(en)
|
2014-04-23 |
2015-10-29 |
Dana-Farber Cancer Institute, Inc. |
Janus kinase inhibitors and uses thereof
|
|
US9862688B2
(en)
|
2014-04-23 |
2018-01-09 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged janus kinase inhibitors and uses thereof
|
|
CN105130973B
(zh)
*
|
2014-05-26 |
2018-05-01 |
海南国瑞堂中药制药有限公司 |
5-吡啶基-2-氨基-苯并[d]噁唑衍生物及其制备方法和用途
|
|
EP3148564B1
(en)
|
2014-06-02 |
2020-01-08 |
Children's Medical Center Corporation |
Methods and compositions for immunomodulation
|
|
JP6854762B2
(ja)
|
2014-12-23 |
2021-04-07 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
サイクリン依存性キナーゼ７（ｃｄｋ７）の阻害剤
|
|
USRE50776E1
(en)
|
2015-03-27 |
2026-02-03 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
|
WO2016201370A1
(en)
|
2015-06-12 |
2016-12-15 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
|
AU2016319125B2
(en)
|
2015-09-09 |
2021-04-08 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
|
WO2017083835A1
(en)
*
|
2015-11-13 |
2017-05-18 |
The Trustees Of Columbia University In The City Of New York |
Inhibition of tor complex 2 increases immunity against bacterial infection
|
|
WO2017156350A1
(en)
|
2016-03-09 |
2017-09-14 |
K-Gen, Inc. |
Methods of cancer treatment
|
|
WO2018017435A1
(en)
*
|
2016-07-22 |
2018-01-25 |
Accro Bioscience Inc. |
Heteroaryl compounds as inhibitors of necrosis, composition and application thereof
|
|
CN107641118B
(zh)
*
|
2016-07-22 |
2020-11-06 |
爱科诺生物医药股份有限公司 |
具有细胞坏死抑制活性的化合物及其组合物和应用
|
|
EP3600270B1
(en)
*
|
2017-03-31 |
2023-06-14 |
Aurigene Oncology Limited |
Compounds and compositions for treating hematological disorders
|
|
AU2018289581C1
(en)
*
|
2017-06-23 |
2025-01-30 |
VelosBio Inc. |
ROR1 antibody immunoconjugates
|
|
WO2018237370A1
(en)
*
|
2017-06-23 |
2018-12-27 |
Accro Bioscience Inc. |
Heteroaryl compounds as inhibitors of necrosis, composition and method using the same
|
|
CN109111464B
(zh)
*
|
2017-06-23 |
2021-02-26 |
爱科诺生物医药股份有限公司 |
一种具有细胞坏死抑制活性的杂环化合物
|
|
AU2018346051B2
(en)
|
2017-10-02 |
2022-11-10 |
1st Biotherapeutics Inc. |
Benzothiazol compounds and methods using the same for treating neurodegenerative disorders
|
|
CA3102279A1
(en)
|
2018-06-01 |
2019-12-05 |
Cornell University |
Combination therapy for pi3k-associated disease or disorder
|
|
WO2019234243A1
(en)
|
2018-06-08 |
2019-12-12 |
Ac Immune Sa |
Novel compounds for diagnosis
|
|
EP3810132A4
(en)
|
2018-06-25 |
2022-06-22 |
Dana-Farber Cancer Institute, Inc. |
TAIRE FAMILY KINASE INHIBITORS AND RELATED USES
|
|
CN113164466B
(zh)
|
2018-09-11 |
2025-07-08 |
柯瑞斯公司 |
使用具有锌结合部分的磷酸肌醇3-激酶抑制剂的联合治疗
|
|
CN109320511A
(zh)
*
|
2018-10-26 |
2019-02-12 |
广安凯特制药有限公司 |
一种高纯度帕博西尼中间体产品及其制备方法
|
|
US12281126B2
(en)
|
2018-12-28 |
2025-04-22 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 and uses thereof
|
|
AU2020224401A1
(en)
|
2019-02-22 |
2021-10-14 |
1ST Biotherapeutics, Inc. |
Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders
|
|
EP3934702B1
(en)
*
|
2019-03-07 |
2024-05-08 |
1st Biotherapeutics, Inc. |
[ 18f]-labeled benzothiazole derivative as pet radiotracer
|
|
US10385046B1
(en)
|
2019-03-19 |
2019-08-20 |
1ST Biotherapeutics, Inc. |
Processes for preparing benzothiazol compounds and methods of using the same for treating neurodegenerative disorders
|
|
KR20210134065A
(ko)
*
|
2019-03-28 |
2021-11-08 |
주식회사 퍼스트바이오테라퓨틱스 |
벤조티아졸 화합물의 약제학적 염, 다형체 및 이들의 제조 방법
|
|
CN110256466A
(zh)
*
|
2019-07-31 |
2019-09-20 |
昆山迪安医学检验实验室有限公司 |
一种噻唑[5,4-b]-吡啶基生物活性化合物的制备方法及其抗肿瘤活性的检测
|
|
CN118767143A
(zh)
|
2019-12-12 |
2024-10-15 |
听治疗有限责任公司 |
用于预防和治疗听力损失的组合物和方法
|
|
US12570638B2
(en)
|
2020-05-20 |
2026-03-10 |
Sail Biomedicines, Inc. |
Fused imidazole derivatives as AHR antagonists
|
|
US20230234967A1
(en)
*
|
2020-05-28 |
2023-07-27 |
Senda Biosciences, Inc. |
Fused Azole Heterocycles as AHR Antagonists
|
|
US12398156B2
(en)
*
|
2020-08-21 |
2025-08-26 |
1ST Biotherapeutics, Inc. |
Compounds for prevention or treatment of neurodegenerative disorders
|
|
CN115968362B
(zh)
*
|
2020-08-21 |
2025-06-13 |
第一生物治疗股份有限公司 |
作为pet放射性示踪剂的[18f]-标记的咪唑并吡啶衍生物
|
|
WO2022064459A1
(en)
*
|
2020-09-28 |
2022-03-31 |
1ST Biotherapeutics, Inc. |
Indazoles as hematopoietic progenitor kinase 1 (hpk1) inhibitors and methods of using same
|
|
EP4319750A4
(en)
|
2021-04-08 |
2025-02-26 |
Curis, Inc. |
COMBINATION THERAPIES FOR THE TREATMENT OF CANCER
|
|
WO2023288046A1
(en)
|
2021-07-15 |
2023-01-19 |
President And Fellows Of Harvard College |
Compositions and methods relating to cells with adhered particles
|
|
CZ2023489A3
(cs)
*
|
2023-12-15 |
2025-05-28 |
Univerzita Hradec Králové |
1-(3-Chlor-4-hydroxyfenyl)-3-(6-((trifluormethyl)thio)benzo[d]thiazol-2-yl)močovina pro použití pro léčbu rakoviny
|
|
GB202415232D0
(en)
|
2024-10-16 |
2024-11-27 |
Nacamed As |
Composition
|